Global Eye Melanoma Market Size
The Eye Melanoma industry is projected to grow from USD 7.29 Billion in 2024 to USD 18.41 Billion by 2034, exhibiting a compound annual growth rate (CAGR) of 10.7% during the forecast period
A cancer that affects cells that make melanin is called melanoma. Ocular melanoma, or eye melanoma, is a type of cancer that arises in the middle of the three layers of the eye: the uvea, retina, and sclera. The sensation of flashes or dust particles in one's vision (floaters), a growing dark spot on the iris, a change in the pupil's shape in the center of the eye, poor or blurry vision in one eye, and loss of peripheral vision are among the early symptoms of eye melanoma. However, later symptoms also include these same symptoms. Trans pupillary thermotherapy, surgical resection procedures, and laser techniques are also utilized in the course of treatment.
The COVID-19 pandemic's effects on the market
Due to the new coronavirus's devastating effects, which have devastated all other markets, the global market for eye melanoma suffered severe financial losses. Modern techniques like transpupillary thermotherapy, laser surgery, and resection are used to treat eye melanoma. Due to the rise in connected occurrences, authorities have been forced to accelerate further research and development activities and increase funding for the process. This has allowed the market to grow more robust and stable even amid the deadly COVID-19 virus epidemic.